22-47 Dr. James Mackey, President & CEO, Aristea Therapeutics

Too much of a good thing spells trouble - in this case, that would be neutrophils – the white blood cells that act as our immune system’s first line of defense. It's called PPP, or Palmoplantar Pustulosis. Dr. James Mackey is the President & CEO of Aristea Therapeutics.